A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
← catalyst calendarNCT06653387 · readout in 92 d
Sponsored by InspireMD (industry) · NSPR — their whole pipeline →. With Washington University School of Medicine, TriHealth Inc., NAMSA.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
50estimated
Sites
8
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-11-20 | actual | When the study began enrolling |
| Primary completion | 2026-11-20 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-11-20 | estimated | The whole study's end, after follow-up |
| First posted | 2024-10-22 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-05-31 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Carotid Artery Diseases
Intervention
- Device: CGuard Prime 80cm stent system
Primary outcomes
what the primary-completion date above is the date OFAcute device success
measured From enrollment to end of follow-up at 1 year
Technical success
measured From enrollment to end of follow-up at 1 year
Permalink · NSPR's whole pipeline · Catalyst calendar · Every registered study · What changed